SHA: 603222

Company Drug

Jiangxi Jemincare Group Secures Clinical Trial Approvals for Six Drugs in China and the US

Fineline Cube Dec 26, 2023

China-based Jiangxi Jemincare Group (SHA: 603222) has announced receiving clinical trial approvals for six of...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod